Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / HRTX - Heron Therapeutics wins Health Canada approval of Zynrelef for postoperative pain

HRTX - Heron Therapeutics wins Health Canada approval of Zynrelef for postoperative pain

Heron Therapeutics Inc.
Health Canada has approved Heron Therapeutics' (NASDAQ:HRTX) Zynrelef (bupivacaine and meloxicam extended-release solution) for postoperative pain. The company said the approval is the first for an extended-release local anesthetic in the country. The approval is for for postoperative analgesia after bunionectomy, open inguinal herniorrhaphy, and total knee arthroplasty surgical procedures. Read why Seeking Alpha contributor Biologics calls Heron (HRTX) a buy.

For further details see:

Heron Therapeutics wins Health Canada approval of Zynrelef for postoperative pain
Stock Information
Company Name: Heron Therapeutics Inc.
Stock Symbol: HRTX
Market: NASDAQ
Website: herontx.com
Menu
HRTX HRTX Quote HRTX Short HRTX News HRTX Articles HRTX Message Board
Get HRTX Alerts

News, Short Squeeze, Breakout and More Instantly...